Published on:

FDA approves new Botox warning

The FDA recently announced that it approved a new warning on Allergan Inc.’s Botox about the possibility of life-threatening breathing or swallowing problems. The FDA also said that it is changing the generic names for Botox to avoid medication errors.

To read more about the FDA warning approval.